Bayer’s Roundup empire is under siege, with billions in lawsuit settlements and more than 67,000 cases still active.
Now the company is pinning its hopes on the highest court in the United States. If Bayer’s legal team succeeds, they could shut the door on these cancer claims — not just for Roundup, but potentially for other controversial pesticides too.
In June 2025, Bayer formally petitioned the U.S. Supreme Court to rule that federal pesticide labeling laws should override state-based “failure to warn” lawsuits, arguing that their federally approved Roundup label should shield them from local claims of inadequate cancer warnings. In legal terms, this is called “federal preemption,” and it could change the entire landscape of pesticide liability.
But what does that mean for consumers, farmers, and communities in New Zealand? And if Bayer wins, does that risk setting a precedent that undermines local protections worldwide?
What Is Bayer Asking the Supreme Court to Decide?
At the heart of Bayer’s argument is the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). This U.S. law requires federal approval of pesticide labeling. Bayer argues that if Roundup’s warning label was approved by the Environmental Protection Agency (EPA), then states should not be able to demand a different warning through state tort law.
Put another way: if a federal agency gave the green light, Bayer believes no jury in California, Missouri, or anywhere else should be allowed to second-guess that label in court.
This is a powerful legal shield — if the Supreme Court agrees, it could effectively immunize Bayer (and by extension, other pesticide makers) from state-based lawsuits claiming they failed to warn about cancer risks.
In January 2026, the U.S. Supreme Court agreed to hear Bayer’s federal preemption argument, marking one of the most consequential pesticide liability cases in modern U.S. legal history. Oral arguments were heard in April 2026, and a ruling is now expected later this year.
What Happens If Bayer Wins?
If Bayer convinces the Supreme Court that federal law preempts these local lawsuits, it would deliver a huge victory for the company.
- Many existing cancer claims could face dismissal or major legal hurdles
- Bayer would no longer face a wave of multi-million or billion-dollar jury awards
- Other pesticide manufacturers could use the same legal precedent to avoid local claims
- Regulators might become the only pathway to challenge pesticide safety, removing the check of citizen-led court challenges
For cancer survivors and their families, it would be a devastating loss. It could also chill future litigation against powerful agrichemical companies — even if evidence emerges showing a product causes harm.
What Happens If Bayer Loses?
If the Supreme Court declines to hear the case or rules against Bayer, then the floodgates stay open:
- Ongoing lawsuits can proceed in state courts
- Bayer could face billions more in damages
- Juries will continue hearing evidence of Monsanto’s ghostwriting, PR manipulation, and its knowledge of Roundup’s cancer risks
- Other pesticide makers might also become targets of similar lawsuits
Such an outcome could also signal to regulators that federally approved does not automatically mean safe — and that juries will keep holding corporations accountable where the system fails.
Why Legal Experts Say This Case Could Reach Far Beyond Roundup
Legal experts following the case say the implications could extend well beyond glyphosate itself.
At the centre of the dispute is a broader question about corporate accountability: if a federal regulator approves a product label, should companies then be protected from lawsuits claiming the warnings were inadequate?
Bayer argues that allowing individual states to impose their own liability standards creates an impossible situation for manufacturers. Critics argue the opposite — that removing state-level legal challenges could weaken one of the few remaining mechanisms ordinary citizens have to hold large corporations accountable when safety concerns emerge years later.
That matters because many major environmental and public health controversies did not begin with regulators sounding the alarm. In numerous cases involving tobacco, asbestos, PFAS, opioids, and pesticides, legal discovery processes and civil lawsuits helped expose internal documents, industry influence, ghostwriting, or scientific disputes that were not fully visible to the public beforehand.
If the U.S. Supreme Court ultimately sides with Bayer’s federal preemption argument, legal analysts say it could strengthen the ability of other chemical manufacturers to argue that federal approval should shield them from similar “failure to warn” claims in state courts.
Supporters of Bayer’s position say this would create greater regulatory consistency and reduce unpredictable litigation. Opponents fear it could shift even more power toward federal agencies and industry-backed assessments, while making it harder for communities, workers, and consumers to challenge products once they are already widely used.
Whatever the final ruling, the outcome is likely to influence future debates over pesticides, chemical exposure, product liability, and the balance of power between regulators, corporations, and the public.
What Could This Mean for New Zealand?
You might wonder: does a U.S. Supreme Court fight matter here in New Zealand?
Actually, yes. Bayer products are still sold under license in New Zealand, and the company’s global legal moves can shape regulatory thinking everywhere.
New Zealand’s EPA relies on many of the same international studies that U.S. courts are now testing under cross-examination. If Bayer succeeds in closing off local lawsuits in America, it might embolden regulators here to lean even more heavily on industry-approved science, rather than encouraging independent reviews.
It’s also worth asking whether New Zealand’s own system — where local councils sometimes try to ban glyphosate but run into national rules — could face similar “preemption” battles. If Bayer’s legal theory wins, it might inspire copycat arguments anywhere communities try to push back on chemical use.
In that sense, this U.S. case is a bellwether: it will show whether corporate pesticide makers can shut down challenges from communities and cancer survivors — not just in America, but anywhere regulators look for a precedent.
Who Gets to Decide What Is Safe?
Bayer’s Supreme Court move isn’t just about money. It is a fight to reshape the rules of accountability — to decide whether local courts and juries still have the power to question what corporations and federal regulators claim is safe.
For New Zealand, that question should resonate deeply. Our farmers, councils, and communities deserve the right to challenge harmful chemicals and protect public health, no matter what a powerful company might argue.
As the U.S. Supreme Court weighs this case, the glyphosate story will keep evolving — and so should our commitment to asking:
Who decides what is safe, and whose voices get left out of that decision?
Further Reading
Bayer’s Supreme Court battle over Roundup is no longer just a legal dispute between one company and a group of cancer plaintiffs. It has become part of a much larger debate about corporate accountability, federal regulation, pesticide safety, and whether communities still have the right to challenge products long after regulators approve them.
The resources below provide additional context on the legal arguments, the scientific controversy surrounding glyphosate, and the wider implications this case may have for future pesticide litigation.
Monsanto v. Durnell – U.S. Supreme Court Docket
Official U.S. Supreme Court case page tracking Bayer’s federal preemption challenge, filings, oral arguments, and procedural developments surrounding the Roundup litigation.
U.S. Supreme Court Hears Bayer’s Fight Against Roundup Lawsuits
Reuters, April 2026: By Andrew Chung and John Kruzel
Reuters coverage of the April 2026 oral arguments, including reactions from the Justices and the broader implications for pesticide liability in the United States.
Bayer Renews Bid for Supreme Court Intervention
Reuters, April 2025: By Ludwig Burger and Brendan Pierson
Background coverage explaining Bayer’s federal preemption strategy and why the company considers the ongoing litigation financially unsustainable.
Federal Preemption: A Legal Primer
Congressional Research Service
A plain-language overview of how federal preemption works in U.S. law and why it can dramatically affect consumer lawsuits and state-level protections.
EPA: Glyphosate Rules and Regulation
EPA, New Zealand
Official guidance on glyphosate regulation in New Zealand — crucial context for evaluating the U.S. Supreme Court fight and local debates.
Bayer Asks U.S. Supreme Court to Block Roundup Lawsuits
AP News, April 2025
Coverage of Bayer’s Supreme Court petition, focusing on federal preemption claims and its potential impact on legal immunity and agriculture.
Bayer Warns Roundup Could End Without Legal Protections
Wall Street Journal, April 2025
Insight into Bayer’s warning that continued litigation could drive Roundup off the market — and how it’s lobbying for legal safety nets.
Federal Preemption: A Legal Primer
Congressional Research Service, May 2023
An authoritative explainer of how federal law can override state tort claims — essential to understanding Bayer’s high-stakes legal argument.
Further Reading on No More Glyphosate NZ
Settling to Silence: Why Bayer Prefers Deals
Our own investigation into Bayer’s strategy of settling Roundup cases — and how that strategy may be faltering as jury verdicts pile up.
Roundup Cancer Lawsuit: What the U.S. Verdict Means for New Zealand
Analysis of the billion‑dollar Georgia verdict and its implications for glyphosate policy and public sentiment in Aotearoa.
The Monsanto Papers by Carey Gillam (2021)
Gillam unveils how internal Monsanto documents revealed hidden tactics — essential reading to understand today’s courtroom explosions.
As Bayer tries to rewrite the rules on liability, these readings will challenge you to question whose voices get heard in the fight for a safer, fairer food system — and whose get silenced.
Image Source & Attribution
We’re grateful to the talented photographers and designers whose work enhances our content. The feature image on this page is by MichaelVi.
